Production (Stage)
Collegium Pharmaceutical, Inc.
COLL
$29.71
$0.531.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.89M | 69.19M | 88.59M | 99.89M | 93.29M |
| Total Depreciation and Amortization | 190.29M | 169.16M | 148.11M | 143.52M | 146.41M |
| Total Amortization of Deferred Charges | 5.60M | 6.02M | 6.56M | 7.47M | 8.13M |
| Total Other Non-Cash Items | 23.72M | 15.59M | 24.30M | 26.92M | 20.21M |
| Change in Net Operating Assets | -65.07M | -54.98M | -73.89M | -1.11M | 40.98M |
| Cash from Operations | 198.44M | 204.98M | 193.67M | 276.69M | 309.02M |
| Capital Expenditure | -1.88M | -1.65M | -1.25M | -1.07M | -853.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -267.54M | -267.54M | -267.54M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.89M | -18.57M | -32.31M | -54.89M | -87.91M |
| Cash from Investing | -279.31M | -287.76M | -301.09M | -55.95M | -88.76M |
| Total Debt Issued | 325.00M | 325.00M | 319.46M | 6.28M | 5.85M |
| Total Debt Repaid | -275.97M | -305.66M | -335.34M | -216.55M | -183.33M |
| Issuance of Common Stock | 8.57M | 11.07M | 14.14M | 14.11M | 9.65M |
| Repurchase of Common Stock | -76.91M | -79.20M | -79.12M | -129.15M | -88.50M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.38M | -11.83M | -6.28M | -6.28M | -6.28M |
| Cash from Financing | -31.69M | -60.60M | -87.15M | -331.59M | -262.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.56M | -143.38M | -194.57M | -110.86M | -42.37M |